Dorene Markel

Dorene Markel
Assistant Research Scientist Emerita
Learning Health Sciences
Medical School
[email protected]
Available to mentor
Dorene Markel
Dorene Markel
Assistant Research Scientist Emeritus/a
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    BIO

    Senior Advisor, Mary Tyler Moore Vision Initiative

    Ms. Markel has been the Senior Advisor to the Mary Tyler Moore Vision Initiative since July 2024 after serving as the founding Managing Director for the previous two years. As the Managing Director, she worked with Dr. Levine and the leadership team to create the Mary Tyler Moore Vision Initiative and launch its platform programs.

    Ms. Markel brings extensive experience to her roles from four decades of leadership service at the University of Michigan (UM), with specialized expertise in creating and managing clinical research and diabetes initiatives. Her past achievements include: working with Dr. Francis Collins to create the NIH-funded UM Human Genome Center and serving as the Center’s Human Studies Core Director; serving as the Administrative Director of the NIH-funded UM General Clinical Research Center; as founding Administrative Director of the Center for the Advancement of Clinical Research; as founding Administrative Director of the NIH-funded Michigan Institute for Clinical and Health Research; and as the first Director for Clinical and Translational Research for the UM Medical School. She was the founding Director of the Brehm Center for Diabetes Research and manager of the Brehm Coalition; founding Managing Director of M-Diabetes; and founding Managing Director of the Elizabeth Weiser Caswell Diabetes Institute. Ms. Markel retired from UM in 2022 and retains an active emeritus faculty position in the UM Department of Learning Health Sciences. She has extensive experience in ethical and regulatory issues in human research having served on the Michigan Medicine and Castle IRBs. Ms. Markel received her B.S. from Michigan Technological University in Biological Sciences; her M.S. from the University of Michigan Medical School, Department of Human Genetics, specializing in Genetic Counseling; and her M.H.S.A (Health Services Administration) degree from the University of Michigan School of Public Health, Department of Health Management and Policy.

    Links

    • Mary Tyler Moore Vision Initiative

    Qualifications

    • Master of Health Services Administration, Health Services Administration
      University of Michigan–Ann Arbor, Ann Arbor, United States
      1988 - 1991
    • Master of Science, Human Genetics/Genetic Counseling
      University of Michigan Medical School, Ann Arbor, United States
      1982 - 1983
    • Bachelors Degree: Biological Sciences, Biological Sciences
      Michigan Technological University, Houghton, United States
      1979 - 1981

    Center Memberships

    • Center Member
      Center for History, Humanities, Arts, Social Sciences and Ethics in Medicine
    • Center Member
      Center for Global Health Equity

    Research Overview

    Diabetes Complications
    Diabetic Retinal Disease
    Ethical issues in human genetic research

    Recent Publications

    See All Publications
    • Journal Article
      Diabetic retinal disease cure accelerator: Modernizing staging and endpoints
      Sampani K, Fickweiler W, Markel DS, Faulkner L, Vujosevic S, Peto T, Meyerhoffer O, Eydelman M, Levine SR, Sun JK, Gardner TW, Abramoff MD. Progress in Retinal and Eye Research, 2026 Jul 1; 113: DOI:10.1016/j.preteyeres.2026.101485
    • Journal Article
      Report of the 2023 Mary Tyler Moore Vision Initiative Workshop
      Levine SR, Markel DS, Myers MG, Barunas R, Sun JK, Chang DS, Maguire MG, Vujosevic S, Fort PE, Atkinson M, Baschiera F, Gates C, Hunt JM, King GL, Kretzler M, Lai P, Lewis D, Luhmann UFO, McLeod S, Oxenreiter C, Unsworth S, Chambers W, Aiello LP, Ehrlich J, German CL, Tadayoni R, Wolf RM, Silva P, Carlson E, Gott B, Oxenreiter M, Sexton N, Das A, Gardner TW. Translational Vision Science and Technology, 2025 Jul 1; 14 (7): DOI:10.1167/tvst.14.7.11
      PMID: 40679331
    • Journal Article
      Advancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes
      Fickweiler W, Sampani K, Markel DS, Levine SR, Sun JK, Gardner TW. Translational Vision Science and Technology, 2025 May 1; 14 (5): DOI:10.1167/tvst.14.5.12
      PMID: 40338731
    • Journal Article
      Data Harmonization, Standardization, and Collaboration for Diabetic Retinal Disease (DRD) Research: Report From the 2024 Mary Tyler Moore Vision Initiative Workshop on Data
      Domalpally A, Fickweiler W, Levine SR, Goetz KE, Vanderbeek BL, Lee A, Sundstrom JM, Markel D, Sun JK. Translational Vision Science and Technology, 2024 Oct 1; 13 (10): DOI:10.1167/tvst.13.10.4
      PMID: 39361314
    • Journal Article
      Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop
      Levine SR, Myers MG, Barunas R, Chang DS, Dutta S, Maddess T, Liebmann JM, Sherman S, Eydelman M, Sun JK, Chambers W, Wickström K, Luhmann UFO, Pallinat M, Glassman A, Aiello LP, Markel DS, Gardner TW. Translational Vision Science and Technology, 2023 Nov 1; 12 (11): DOI:10.1167/tvst.12.11.33
      PMID: 38015167
    • Journal Article
      Developing a Weight Navigation Program to Support Personalized and Effective Obesity Management in Primary Care Settings: Protocol for a Quality Improvement Program with an Embedded Single-Arm Pilot Study
      Griauzde DH, Othman A, Dallas C, Oshman L, Gabison J, Markel DS, Richardson CR, Kullgren JT, Piatt G, Heisler M, Kilbourne A, Kraftson A. Primary Health Care Research & Development, 2022 Sep 21; 23: DOI:10.1017/S1463423621000906
    • Journal Article
      Developing a Weight Navigation Program to support personalized and effective obesity management in primary care settings: protocol for a quality improvement program with an embedded single-arm pilot study
      Griauzde DH, Othman A, Dallas C, Oshman L, Gabison J, Markel DS, Richardson CR, Kullgren JT, Piatt G, Heisler M, Kilbourne AM, Kraftson A. Primary health care research & development, 2022 Mar; 23:
    • Journal Article
      Blood Pressure is Associated with Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Patients with Diabetes
      Shah AR, Van Horn AN, Verchinina L, Wichorek M, Su L, Markel D, Gardner TW. Ophthalmology Retina, 2019 Jan 1; 3 (5): 410 - 416.